Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital

Mostrar otras versiones (1)

Recent studies reported the presence of pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) in at least 15% of patients with critical or severe COVID-19 pneumonia. In one study, these auto-Abs were found in almost 20% of deceased patients across all ages. We aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvineau-Grenier, Angélique, Bastard, Paul, Servajean, Antoine, Gervais, Adrian, Rosain, Jérémie, Jouanguy, Emmanuelle, Cobat, Aurélie, Casanova, Jean-Laurent, Rossi, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491850/
https://www.ncbi.nlm.nih.gov/pubmed/34611657
http://dx.doi.org/10.21203/rs.3.rs-915062/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491850/
https://www.ncbi.nlm.nih.gov/pubmed/34611657
http://dx.doi.org/10.21203/rs.3.rs-915062/v1

Ejemplares similares